Journal of Commercial Biotechnology - AOP Journal of Commercial Biotechnology is the definitive international quarterly publication for bioscience business professionals. http://www.palgrave-journals.com/jcb/journal/vaop/ncurrent/rss.rdf Palgrave Macmillan Ltd en Copyright © Palgrave Macmillan Ltd Journal of Commercial Biotechnology 1462-8732 Copyright © Palgrave Macmillan Ltd rights@palgrave.com Journal of Commercial Biotechnology http://www.palgrave-journals.com/pal/images/logos_b_o_w/jcb.gif http://www.palgrave-journals.com/jcb/ Intellectual property landscape and patenting opportunity in biofuels http://feeds.palgrave-journals.com/~r/jcb/rss/aop/journal/~3/-3mi2MtJToA/jcb.2009.1 Intellectual property landscape and patenting opportunity in biofuels

Journal of Commercial Biotechnology advance online publication, March 17, 2009. doi:10.1057/jcb.2009.1

Author: Ramasamy Mannan

]]> Intellectual property landscape and patenting opportunity in biofuels Ramasamy Mannan doi:10.1057/jcb.2009.1 Journal of Commercial Biotechnology advance online publication, March 17, 2009 2009-03-17 Journal of Commercial Biotechnology March 17, 2009 10.1057/jcb.2009.1 http://dx.doi.org/10.1057/jcb.2009.1 aop current http://dx.doi.org/10.1057/jcb.2009.1 Challenges and opportunities in the licensing of renewable technologies http://feeds.palgrave-journals.com/~r/jcb/rss/aop/journal/~3/er3cXhMcazI/jcb.2009.10 Challenges and opportunities in the licensing of renewable technologies

Journal of Commercial Biotechnology advance online publication, May 26, 2009. doi:10.1057/jcb.2009.10

Authors: Meredith Lloyd-Evans, Mike Gilbert & Ilian P Iliev

]]> Challenges and opportunities in the licensing of renewable technologies Meredith Lloyd-Evans Mike Gilbert Ilian P Iliev doi:10.1057/jcb.2009.10 Journal of Commercial Biotechnology advance online publication, May 26, 2009 2009-05-26 Journal of Commercial Biotechnology May 26, 2009 10.1057/jcb.2009.10 http://dx.doi.org/10.1057/jcb.2009.10 aop current http://dx.doi.org/10.1057/jcb.2009.10 Pharmaceutical royalties in licensing deals: No place for the 25 per cent rule of thumb http://feeds.palgrave-journals.com/~r/jcb/rss/aop/journal/~3/g8qdDWDbNcg/jcb.2009.13 Pharmaceutical royalties in licensing deals: No place for the 25 per cent rule of thumb

Journal of Commercial Biotechnology advance online publication, April 21, 2009. doi:10.1057/jcb.2009.13

Authors: Nigel Borshell & Adrian Dawkes

]]> Pharmaceutical royalties in licensing deals: No place for the 25 per cent rule of thumb Nigel Borshell Adrian Dawkes doi:10.1057/jcb.2009.13 Journal of Commercial Biotechnology advance online publication, April 21, 2009 2009-04-21 Journal of Commercial Biotechnology April 21, 2009 10.1057/jcb.2009.13 http://dx.doi.org/10.1057/jcb.2009.13 aop current http://dx.doi.org/10.1057/jcb.2009.13 Biotechnology marketing: Insider and outsider views http://feeds.palgrave-journals.com/~r/jcb/rss/aop/journal/~3/owYRtpdKOWI/jcb.2009.16 Biotechnology marketing: Insider and outsider views

Journal of Commercial Biotechnology advance online publication, May 26, 2009. doi:10.1057/jcb.2009.16

Authors: Päivi Eriksson & Heidi Rajamäki

]]> Biotechnology marketing: Insider and outsider views Päivi Eriksson Heidi Rajamäki doi:10.1057/jcb.2009.16 Journal of Commercial Biotechnology advance online publication, May 26, 2009 2009-05-26 Journal of Commercial Biotechnology May 26, 2009 10.1057/jcb.2009.16 http://dx.doi.org/10.1057/jcb.2009.16 aop current http://dx.doi.org/10.1057/jcb.2009.16 Ethiopia: Biotechnology for development http://feeds.palgrave-journals.com/~r/jcb/rss/aop/journal/~3/syYTZ5Iof_o/jcb.2009.21 Ethiopia: Biotechnology for development

Journal of Commercial Biotechnology advance online publication, August 11, 2009. doi:10.1057/jcb.2009.21

Author: Desta Berhe Sbhatu

]]> Ethiopia: Biotechnology for development Desta Berhe Sbhatu doi:10.1057/jcb.2009.21 Journal of Commercial Biotechnology advance online publication, August 11, 2009 2009-07-11 Journal of Commercial Biotechnology August 11, 2009 10.1057/jcb.2009.21 http://dx.doi.org/10.1057/jcb.2009.21 aop current http://dx.doi.org/10.1057/jcb.2009.21 Follow-on biologic drug competition – No need for new marketing exclusivities http://feeds.palgrave-journals.com/~r/jcb/rss/aop/journal/~3/rwANvQNXB8g/jcb.2009.27 Follow-on biologic drug competition – No need for new marketing exclusivities

Journal of Commercial Biotechnology advance online publication, September 22, 2009. doi:10.1057/jcb.2009.27

Authors: Michael S Wroblewski & Elizabeth A Jex

]]> Follow-on biologic drug competition – No need for new marketing exclusivities Michael S Wroblewski Elizabeth A Jex doi:10.1057/jcb.2009.27 Journal of Commercial Biotechnology advance online publication, September 22, 2009 2009-07-22 Journal of Commercial Biotechnology September 22, 2009 10.1057/jcb.2009.27 http://dx.doi.org/10.1057/jcb.2009.27 aop current http://dx.doi.org/10.1057/jcb.2009.27 Commercializing synthetic biology: Socio-ethical concerns and challenges under intellectual property regime http://feeds.palgrave-journals.com/~r/jcb/rss/aop/journal/~3/gXMlsaStF-I/jcb.2009.28 Commercializing synthetic biology: Socio-ethical concerns and challenges under intellectual property regime

Journal of Commercial Biotechnology advance online publication, October 27, 2009. doi:10.1057/jcb.2009.28

Authors: Trichi Saukshmya & Archana Chugh

]]> Commercializing synthetic biology: Socio-ethical concerns and challenges under intellectual property regime Trichi Saukshmya Archana Chugh doi:10.1057/jcb.2009.28 Journal of Commercial Biotechnology advance online publication, October 27, 2009 2009-10-27 Journal of Commercial Biotechnology October 27, 2009 10.1057/jcb.2009.28 http://dx.doi.org/10.1057/jcb.2009.28 aop current http://dx.doi.org/10.1057/jcb.2009.28 From carbon to carbohydrates: Corporate strategies for biopolymer technology development http://feeds.palgrave-journals.com/~r/jcb/rss/aop/journal/~3/qMf3tv_K07c/jcb.2009.30 From carbon to carbohydrates: Corporate strategies for biopolymer technology development

Journal of Commercial Biotechnology advance online publication, October 27, 2009. doi:10.1057/jcb.2009.30

Author: Avrath Chadha

]]> From carbon to carbohydrates: Corporate strategies for biopolymer technology development Avrath Chadha doi:10.1057/jcb.2009.30 Journal of Commercial Biotechnology advance online publication, October 27, 2009 2009-10-27 Journal of Commercial Biotechnology October 27, 2009 10.1057/jcb.2009.30 http://dx.doi.org/10.1057/jcb.2009.30 aop current http://dx.doi.org/10.1057/jcb.2009.30 Practical approaches to early stage life sciences technology valuations http://feeds.palgrave-journals.com/~r/jcb/rss/aop/journal/~3/_3bu4ralNwI/jcb.2009.31 Practical approaches to early stage life sciences technology valuations

Journal of Commercial Biotechnology advance online publication, November 3, 2009. doi:10.1057/jcb.2009.31

Author: Stephen Mayhew

]]> Practical approaches to early stage life sciences technology valuations Stephen Mayhew doi:10.1057/jcb.2009.31 Journal of Commercial Biotechnology advance online publication, November 3, 2009 200-11-03 Journal of Commercial Biotechnology November 3, 2009 10.1057/jcb.2009.31 http://dx.doi.org/10.1057/jcb.2009.31 aop current http://dx.doi.org/10.1057/jcb.2009.31 Biotechnology in the capital region of Europe http://feeds.palgrave-journals.com/~r/jcb/rss/aop/journal/~3/XE1sTRXx4sk/jcb.2009.34 Biotechnology in the capital region of Europe

Journal of Commercial Biotechnology advance online publication, November 10, 2009. doi:10.1057/jcb.2009.34

Author: Jan Wauters

]]> Biotechnology in the capital region of Europe Jan Wauters doi:10.1057/jcb.2009.34 Journal of Commercial Biotechnology advance online publication, November 10, 2009 200-11-10 Journal of Commercial Biotechnology November 10, 2009 10.1057/jcb.2009.34 http://dx.doi.org/10.1057/jcb.2009.34 aop current http://dx.doi.org/10.1057/jcb.2009.34 The current M&A environment and its strategic implications for emerging biotherapeutics companies http://feeds.palgrave-journals.com/~r/jcb/rss/aop/journal/~3/SLQI_oFN4c8/jcb.2009.35 The current M&A environment and its strategic implications for emerging biotherapeutics companies

Journal of Commercial Biotechnology advance online publication, November 10, 2009. doi:10.1057/jcb.2009.35

Authors: Mohan Sowlay & Scott Lloyd

]]> The current M&A environment and its strategic implications for emerging biotherapeutics companies Mohan Sowlay Scott Lloyd doi:10.1057/jcb.2009.35 Journal of Commercial Biotechnology advance online publication, November 10, 2009 200-11-10 Journal of Commercial Biotechnology November 10, 2009 10.1057/jcb.2009.35 http://dx.doi.org/10.1057/jcb.2009.35 aop current http://dx.doi.org/10.1057/jcb.2009.35 Exploring technology agglomeration patterns for multinational pharmaceutical and biotechnology firms http://feeds.palgrave-journals.com/~r/jcb/rss/aop/journal/~3/dDt6UVBig_g/jcb.2009.8 Exploring technology agglomeration patterns for multinational pharmaceutical and biotechnology firms

Journal of Commercial Biotechnology advance online publication, April 7, 2009. doi:10.1057/jcb.2009.8

Authors: Mark J Ahn, Michael Meeks, Sally Davenport & Rebecca Bednarek

]]> Exploring technology agglomeration patterns for multinational pharmaceutical and biotechnology firms Mark J Ahn Michael Meeks Sally Davenport Rebecca Bednarek doi:10.1057/jcb.2009.8 Journal of Commercial Biotechnology advance online publication, April 7, 2009 Journal of Commercial Biotechnology April 7, 2009 10.1057/jcb.2009.8 http://dx.doi.org/10.1057/jcb.2009.8 aop current http://dx.doi.org/10.1057/jcb.2009.8